Andy Blauvelt is President of Oregon Medical Research Center in Portland, Oregon, a private dermatology clinical studies business. He received his undergraduate degree in Electrical Engineering at Purdue University, his medical degree at Michigan State University, and his Healthcare MBA from Portland State University/Oregon Health & Science University (OHSU). Dr. Blauvelt trained in dermatology at the University of Miami and in basic immunology/virology under the direction of Steve Katz at the National Institutes of Health (NIH). He has held senior staff tenured positions at the NIH, OHSU, and the Portland VA Medical Center. Andy’s clinical and research expertise is in Langerhans cell biology, immunology, virology, psoriasis, atopic dermatitis, and biologic therapies for complex medical dermatology patients, having published over 260 papers and spoken across the world on these topics. Dr. Blauvelt is also an elected member of the American Society for Clinical Investigation (a leading society for physician-scientists), the International Psoriasis Council (the premier group of psoriasis experts in the world), and the International Eczema Council (the premier group of eczema experts in the world).